The bone-derived hormone fibroblast growth factor 23 (FGF23), the regulator of vitamin D and phosphate homeostasis, has been speculated to be implicated, given that anemia, iron deficiency and inflammatory conditions are all known to increase FGF23 expression levels in osteoblasts. The gene discussed is FGF23; the disease is nutritional disorder.